Coagulation laboratory tests

Anticardiolipin antibodies

Last author update: 1 June 2012
Last staff update: 11 September 2020

Copyright: 2002-2024,, Inc.

PubMed Search: Anticardiolipin antibodies [title]

Jeremy C. Parsons, M.D.
Page views in 2023: 106
Page views in 2024 to date: 13
Cite this page: Parsons JC. Anticardiolipin antibodies. website. Accessed April 14th, 2024.
Definition / general
  • One of the two main types of antiphospholipid antibodies (other is lupus anticoagulant) often seen in conjunction with beta2 - glycoprotein antibodies

  • Indications:
    • Patients with venous thromboembolism (particularly if no family history or associated with autoimmune disease)
    • Unexplained stroke (young person or autoimmune disease), cerebral venous thrombosis, recurrent or late pregnancy loss
    • Test may be considered for arterial thrombosis, particularly in young patient or no documented atherosclerosis

  • Specimen:
    • Serum (red top)

  • Methodology:
    • ELISA test to recognize proteins (not actually cardiolipin) bound to a microtiter plate
    • Tests for anti - prothrombin and anti - beta2 - GPI antibodies have had limited prospective studies
    • IgG recommended to evaluated hypercoagulability (risk with IgM or IgA antibodies is uncertain)
    • Increased titers are most closely associated with hypercoagulability
    • 200 - 400x more sensitive than VDRL, but patient with syphilitic infection may have positive anticardiolipin antibody test results
    • High sensitivity plates have greater antigenic density on microtiter plate, may be irradiated for greater antigenic density and to facilitate bivalent bonding of plasma antibodies
    • 62% positivity in patients with SLE or other autoimmune results
    • To demonstrate antibody persistence, positive test must be confirmed by repeat testing after 6 weeks
    • Transient antibodies are not strongly associated with thrombosis
Back to top
Image 01 Image 02